NCT02114892View on ClinicalTrials.gov

Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

September 30, 2013

Conditions
Metabolic Syndrome X
Interventions
DRUG

Resveratrol

Resveratrol capsules of 500 mg three times per day before meals with a total dosis of 1500 mg per day.

DRUG

Placebo

Calcined magnesia capsules, 500 mg, three times per day before meals with a total dose per day of 1500 mg

Trial Locations (1)

45037

Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT02114892 - Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | Biotech Hunter | Biotech Hunter